Related Experiment Video

Updated: Jul 5, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Limitations of using a single postdose midazolam concentration to predict CYP3A-mediated drug interactions

Scott R Penzak1, Kristin H Busse, Sarah M Robertson

  • 1Clinical Pharmacokinetics Research Laboratory, National Institutes of Health, Clinical Center Pharmacy Department, Bldg 10, Room 1N 257, Bethesda, MD 20892, USA. spenzak@mail.cc.nih.gov

Journal of Clinical Pharmacology
|April 19, 2008
PubMed

Insights

Single blood samples can estimate midazolam area under the curve (AUC) to predict CYP3A activity. However, wide confidence intervals indicate midazolam AUC is still preferred for drug interaction studies.

Area of Science:

  • Pharmacokinetics
  • Drug Metabolism
  • Enzyme Activity Assays

Background:

  • Midazolam is a standard probe for assessing Cytochrome P450 3A (CYP3A) activity.
  • Determining midazolam's area under the concentration-time curve (AUC) typically requires multiple blood samples.
  • Single-sample strategies are being explored to simplify CYP3A activity assessment.

Purpose of the Study:

  • To evaluate the accuracy of single midazolam concentrations in predicting midazolam AUC.
  • To assess this predictive ability with and without CYP3A modulation by Ginkgo biloba extract (GBE).

Main Methods:

  • Oral midazolam (8 mg) was administered to subjects before and after 28 days of GBE.
  • Blood samples were collected postdose to determine midazolam AUC.
  • Linear regression analyzed the predictive performance of single midazolam concentrations.

Main Results:

  • Midazolam AUC significantly decreased by 34% after GBE administration (geometric mean ratio 0.66; P = .03).
  • Optimal single sampling times shifted from 3.5–5 hours (pre-GBE) to 2–3 hours (post-GBE).
  • Single concentrations between 2–5 hours predicted the AUC reduction, but with wide confidence intervals.

Conclusions:

  • Single midazolam concentrations can indicate CYP3A modulation but lack precision.
  • Intersubject variability in CYP3A activity impacts optimal sampling time prediction.
  • Midazolam AUC remains the preferred method for assessing CYP3A activity in drug-drug interaction studies.

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Related Concept Videos

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...